Integrated Proteins Limited (INTEGFD.BO)
INR 70.93
(2.0%)
INR 70.93
(2.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -594 Thousand | -1.2 Million | -925 Thousand | -923 Thousand | -1.55 Million | 1.43 Million |
| Net Income | 893 Thousand | 309 Thousand | 365 Thousand | 212 Thousand | 55.61 Thousand | 247.49 Thousand |
| Depreciation & Amortization | 264 Thousand | 288 Thousand | 288 Thousand | 288 Thousand | 288.14 Thousand | 288.14 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 280 Thousand | -238 Thousand | -66 Thousand | -37 Thousand | 301.67 Thousand | 786.1 Thousand |
| Other non-cash items | -2.03 Million | -1.56 Million | -1.51 Million | -1.38 Million | -2.19 Million | 111.2 Thousand |
| Investing Cash Flow | 1.48 Million | -6000.00 | 106 Thousand | 240 Thousand | 293.11 Thousand | 222.04 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.48 Million | -6000.00 | 106 Thousand | 240 Thousand | 293.11 Thousand | 222.04 Thousand |
| Financing Cash Flow | -1.56 Million | 1.11 Million | 454 Thousand | 344 Thousand | - | -863.25 Thousand |
| Debt repayment | -1.56 Million | -1.11 Million | -454 Thousand | -344 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -863.25 Thousand |
| Accounts receivables | - | - | - | 36 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 280 Thousand | -238 Thousand | -66 Thousand | -73 Thousand | 301.67 Thousand | 786.1 Thousand |
| Cash at beginning of period | 1.29 Million | 1.38 Million | 1.75 Million | 2.09 Million | 791.75 Thousand | 4.07 Million |
| Cash at end of period | 615 Thousand | 1.29 Million | 1.38 Million | 1.75 Million | 2.09 Million | 791.75 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -678 Thousand | -95 Thousand | -364 Thousand | -339.11 Thousand | 1.29 Million | -3.28 Million |
| Free Cash Flow | -594 Thousand | -1.2 Million | -925 Thousand | -923 Thousand | -1.55 Million | 1.43 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7000.00 | 221 Thousand | 893 Thousand | 813 Thousand | 124 Thousand | -266 Thousand |
| Depreciation & Amortization | - | - | 264 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 280 Thousand | - | - | - |
| Other non-cash items | 7000.00 | -221 Thousand | -2.03 Million | -813 Thousand | -124 Thousand | 266 Thousand |
| Investing Cash Flow | - | - | 1.48 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 1.48 Million | - | - | - |
| Financing Cash Flow | - | - | -1.56 Million | - | - | - |
| Debt repayment | - | - | -1.56 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 280 Thousand | - | - | - |
| Cash at beginning of period | - | - | 1.29 Million | - | - | - |
| Cash at end of period | - | - | 615 Thousand | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -678 Thousand | - | - | - |
| Free Cash Flow | - | - | -594 Thousand | - | - | - |
051900
2597
ISHA
HBM
1519
GNC